Arqueros, C.; Salazar, J.; Gallardo, A.; Andrés, M.; Tibau, A.; Lidia Bell, O.; Artigas, A.; Lasa, A.; Ramón y Cajal, T.; Lerma, E.;
et al. Secreted Protein Acidic and Rich in Cysteine (SPARC) Polymorphisms in Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer Patients. Biomedicines 2023, 11, 3231.
https://doi.org/10.3390/biomedicines11123231
AMA Style
Arqueros C, Salazar J, Gallardo A, Andrés M, Tibau A, Lidia Bell O, Artigas A, Lasa A, Ramón y Cajal T, Lerma E,
et al. Secreted Protein Acidic and Rich in Cysteine (SPARC) Polymorphisms in Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer Patients. Biomedicines. 2023; 11(12):3231.
https://doi.org/10.3390/biomedicines11123231
Chicago/Turabian Style
Arqueros, Cristina, Juliana Salazar, Alberto Gallardo, Marta Andrés, Ariadna Tibau, Olga Lidia Bell, AlÃcia Artigas, Adriana Lasa, Teresa Ramón y Cajal, Enrique Lerma,
and et al. 2023. "Secreted Protein Acidic and Rich in Cysteine (SPARC) Polymorphisms in Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer Patients" Biomedicines 11, no. 12: 3231.
https://doi.org/10.3390/biomedicines11123231
APA Style
Arqueros, C., Salazar, J., Gallardo, A., Andrés, M., Tibau, A., Lidia Bell, O., Artigas, A., Lasa, A., Ramón y Cajal, T., Lerma, E., & Barnadas, A.
(2023). Secreted Protein Acidic and Rich in Cysteine (SPARC) Polymorphisms in Response to Neoadjuvant Chemotherapy in HER2-Negative Breast Cancer Patients. Biomedicines, 11(12), 3231.
https://doi.org/10.3390/biomedicines11123231
